Colonization of the human gut by E. coli and colorectal cancer risk

Clinical Cancer Research

Volumn 20, Issue 4, 2014, Pages 859-867

  Bonnet, Mathilde ^a,b   Buc, Emmanuel ^a,b,c   Sauvanet, Pierre ^a,b,c   Darcha, Claude ^c   Dubois, Damien ^a,b,c   Pereira, Bruno ^c   Dechelotte, Pierre ^c   Bonnet, Richard ^a,b,c   Pezet, Denis ^a,b,c   Darfeuille Michaud, Arlette ^a,b,c  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b USC 2018   (France)

^c UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DIVERTICULOSIS; ESCHERICHIA COLI; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOCARCINOMA; ANIMALS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DIVERTICULUM, COLON; ESCHERICHIA COLI; FEMALE; GASTROINTESTINAL TRACT; HUMANS; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84896713690     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-1343     Document Type: Article

References (36)

1. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-4.
2. O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Ko CY. Are survival rates different for young and older patients with rectal cancer? Dis Colon Rectum 2004;47:2064-9
3. Fearon ER, Vogelstein B. Agenetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
4. Dalton-Griffin L, Kellam P. Infectious causes of cancer and their detection. J Biol 2009;8:67.
5. Zur Hausen H. The search for infectious causes of human cancers: where and why. Virology 2009;392:1-10.
6. Lax AJ. Opinion: bacterial toxins and cancer-a case to answer? Nat Rev Microbiol 2005;3:343-9.
7. Collins D, Hogan AM, Winter DC. Microbial and viral pathogens in colorectal cancer. Lancet Oncol 2010;12:504-12.
8. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012;338:120-3.
9. Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 2012;10:575-82.
10. Swidsinski A, Khilkin M, Kerjaschki D, Schreiber S, Ortner M, Weber J, et al. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 1998;115:281-6.
11. Martin HM, Campbell BJ, Hart CA, Mpofu C, Nayar M, Singh R, et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology 2004;127:80-93.
12. Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology 1998;115:1405-13.
13. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 2004;127:412-21.
14. Thelestam M, Frisan T. Cytolethal distending toxins. Rev Physiol Biochem Pharmacol. 2004;152:111-33.
15. Falzano L, Filippini P, Travaglione S, Miraglia AG, Fabbri A, Fiorentini C. Escherichia coli cytotoxic necrotizing factor 1 blocks cell cycle G2/M transition in uroepithelial cells. Infect Immun. 2006;74:3765-72.
16. Malorni W, Fiorentini C. Is the Rac GTPase-activating toxin CNF1 a smart hijacker of host cell fate? Faseb J 2006;20:606-9.
17. Jubelin G., Chavez CV, Taieb F, Banfield MJ, Samba-Louaka A, Nobe R, et al. Cycle inhibiting factors (CIFs) are a growing family of functional cyclomodulins present in invertebrate and mammal bacterial pathogens. PLoS ONE 2009;4:e4855.
18. Nougayrede JP, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313:848-51.
19. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrede JP. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci U S A 2010;107: 11537-42.
20. Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A, et al. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One 2013;8:e56964.
21. Winter SE, Lopez CA, Baumler AJ. The dynamics of gut-associated microbial communities during inflammation. EMBO Rep. 2013;14: 319-27.
22. Fujimori Y, Fujimori T, Imura J, Sugai T, Yao T, Wada R, et al. An assessment of the diagnostic criteria for sessile serrated adenoma/ polyps: SSA/Ps using image processing software analysis for Ki67 immunohistochemistry. Diagn Pathol 2012;7:59.
23. Carvalho FA, Barnich N, Sivignon A, Darcha C, Chan CH, Stanners CP, et al. Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med. 2009;206:2179-89.
24. Shen XJ, Rawls JF, Randall T, Burcal L, Mpande CN, Jenkins N, et al. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010;1:138-47.
25. Jantscheff P, Terracciano L, Lowy A, Glatz-Krieger K, Grunert F, Micheel B, et al. Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. J Clin Oncol. 2003;21:3638-46.
26. Barnich N, Carvalho FA, Glasser AL, Darcha C, Jantscheff P, Allez M, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest 2007;117:1566-74.
27. Li Y, Kundu P, Seow SW, Matos CT, Aronsson L, Chin KC, et al. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis 2012;33:1231-8.
28. Homburg S, Oswald E, Hacker J, Dobrindt U. Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. FEMS Microbiol Lett 2007;275:255-62.
29. Uronis JM, Jobin C. Microbes and colorectal cancer: is there a relationship? Curr Oncol 2009;16:22-4.
30. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009;15: 1016-22.
31. Xu F, Wang F, Di M, Huang Q, Wang M,Hu H, et al. Classification based on the combination of molecular and pathologic predictors is superior to molecular classification on prognosis in colorectal carcinoma. Clin Cancer Res 2007;13:5082-8.
32. Mulcahy HE, Toner M, Patchett SE, Daly L, O'Donoghue DP. Identifying stageBcolorectal cancer patients at high risk of tumor recurrence and death. Dis Colon Rectum 1997;40:326-31.
33. Noura S, Yamamoto H, Ohnishi T, Masuda N, Matsumoto T, Takayama O, et al. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 2002;20:4232-41.
34. Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Landmann RG, et al. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Dis Colon Rectum 2008;51:503-7.
35. Chin CC, Wang JY, Changchien CR, Huang WS, Tang R. Carcinoma obstruction of the proximal colon cancer and long-term prognosis-obstruction is a predictor of worse outcome inTNMstage II tumor. Int J Colorectal Dis 2010;25:817-22.
36. Stocchi L, Fazio VW, Lavery I, Hammel J. Individual surgeon, pathologist, and other factors affecting lymph node harvest in stage II colon carcinoma. Is a minimum of 12 examined lymph nodes sufficient? Ann Surg Oncol 2011;18:405-12.